New Issue: Orbital Catastrophe Ahead? Read Now

Acne Inflammation Discovery Could Lead to New Treatments

A key player is revealed in the acne-causing immune battle

Thomas Fuchs

Join Our Community of Science Lovers!

If pimples are caused by oily skin, why doesn't a good washing prevent all breakouts? A recent study offers an answer— and maybe a new line of defense.

Pimples contain tiny and discrete bacterial infections. The most commonly involved bacteria are Cutibacterium acnes, which live innocuously on skin cells but can grow out of control when the skin's oily sebum increases and boosts bacterial food supply. What we think of as acne—the pustules, redness and swelling—is a battle between our immune system and these rapidly multiplying bacteria, says dermatologist Richard Gallo of the University of California, San Diego, who led the new study. “For most people, it's not that you're dirty, or you're not washing your face enough,” Gallo explains. “This is a problem with the way your body's immune system is dealing with the bacteria that are supposed to be there.”

If one imagines the immune system and bacteria as being on opposing soccer teams, acne is the beat-up turf at the end of the game. The new study identifies a previously unknown, and particularly turf-mangling, immune system player. Gallo and his colleagues showed in Science Translational Medicine that a structural cell type called a fibroblast (which is not typically considered an immune cell) contributes to the facial face-off. Working with mice and with human skin samples, the scientists found that C. acnes triggers fibroblasts to transform into fat cells that secrete an antimicrobial substance—along with inflammation-causing proteins. The researchers also discovered that retinoids, a powerful and commonly used class of pimple-fighting drug, work partially by blocking fibroblasts' transformation and release of irritating proteins.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Jonette Keri, a clinical dermatologist at the University of Miami Miller School of Medicine, who was not involved in the research, calls the finding an “exciting” new way to think about acne. Because retinoids can have undesirable side effects, she says, pursuing a more targeted way to stop the fibroblasts' transformation would be “fantastic” for clinical treatment.

Maddie Bender is a science writer and a producer at Hawaii Public Radio. She was a 2021 AAAS Mass Media Fellow at Scientific American.

More by Maddie Bender
Scientific American Magazine Vol 326 Issue 6This article was published with the title “Pimple Patrol” in Scientific American Magazine Vol. 326 No. 6 (), p. 23
doi:10.1038/scientificamerican0622-23

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe